Darshan Singh

Darshan Singh

Author is a pharmaceutical professional who is Master in Science (Organic Chemistry) and Diploma in Pharmacy. He has rich experience in pharma manufacturing sector, He Served in many companies as Quality Control Head, and Quality Assurance Head, along with Plant Head supervised all manufacturing processes. He is keen to research of pharma product manufacturing and drugs pharmacology. He is writing on several topics about pharmaceutical products, processes, and SOPs.

Schedule X Drugs List [2025 Update] – Uses & Side Effects

schedule x drugs list

Reviewed and updated as of July 2026. What Is a Schedule X Drug? Schedule X is the strictest drug classification under India’s Drugs and Cosmetics Rules, 1945 — reserved for habit-forming, high-abuse-potential medicines such as barbiturates, amphetamine-type stimulants, and dissociative…

Datroway (Datopotamab Deruxtecan): MOA, Approvals & India

Datroway (Datopotamab Deruxtecan)

Reviewed and updated: 4 July 2026. Regulatory approval status, indications, and India commercial-availability status can change. Verify current status against the primary sources in the References section before making clinical, procurement, or regulatory decisions. In brief: Datopotamab deruxtecan-dlnk is a…

Understanding Schedule H Drugs (2026 Regulatory Guide)

schedule h drugs

Schedule H drugs are prescription medicines regulated under the Drugs and Cosmetics Rules, 1945, and they are sold only on the prescription of a Registered Medical Practitioner. For pharmaceutical manufacturers, marketers, distributors, pharmacies, and compliance teams, understanding Schedule H rules…